Skip to main content
Erschienen in: Indian Journal of Hematology and Blood Transfusion 1/2018

13.12.2017 | Short Communication

Plasma Cell Dyscrasias in India-2017 Updates

verfasst von: Arihant Jain, Pankaj Malhotra

Erschienen in: Indian Journal of Hematology and Blood Transfusion | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Rapid advances are being made in the field of plasma cell dyscrasias. Many abstracts pertaining to the laboratory aspects, clinical features, treatment modalities and outcome of plasma cell dyscrasias were presented at Hematocon 2017. All the total of 24 abstracts pertaining to plasma cell dyscrasias presented at the Hematocon 2017 were reviewed. Out of them 10 were original research and 14 were case reports/short case series. The key findings of original research studies conducted in India are being summarized. Exciting research in the field of plasma cell dyscrasias is being carried out by various centers in the country. Data presented on various aspects of research in plasma cell disorders is encouraging. Multicentric research in the field plasma cell dyscrasias should be encouraged to highlight the various aspects of disease biology and challenges in management unique to our country.
Literatur
1.
Zurück zum Zitat Naithani R (2017) Hematopoietic stem cell transplantation in India-2017 annual update. Indian J Hematol Blood Transfus. Ahead of print Naithani R (2017) Hematopoietic stem cell transplantation in India-2017 annual update. Indian J Hematol Blood Transfus. Ahead of print
2.
Zurück zum Zitat Kadam Amare PS, Jain H, Nikalje S et al (2016) Observation on frequency & clinico-pathological significance of various cytogenetic risk groups in multiple myeloma: an experience from India. Indian J Med Res 144(4):536–543PubMedPubMedCentral Kadam Amare PS, Jain H, Nikalje S et al (2016) Observation on frequency & clinico-pathological significance of various cytogenetic risk groups in multiple myeloma: an experience from India. Indian J Med Res 144(4):536–543PubMedPubMedCentral
3.
Zurück zum Zitat Jain H, Shetty D, Deshpande Y et al (2017) Retrospective fish analysis in 95 multiple myeloma cases and their co-relation with clinico-biochemical parameters. Abstract PCD-05. Indian J Hematol Blood Transfus 33(Abstract Issue: 58th Annual Conference of Indian Society of Hematology and Blood Transfusion; November 2017):S99 Jain H, Shetty D, Deshpande Y et al (2017) Retrospective fish analysis in 95 multiple myeloma cases and their co-relation with clinico-biochemical parameters. Abstract PCD-05. Indian J Hematol Blood Transfus 33(Abstract Issue: 58th Annual Conference of Indian Society of Hematology and Blood Transfusion; November 2017):S99
5.
Zurück zum Zitat Greenberg AJ, Philip S, Paner A et al (2015) Racial differences in primary cytogenetic abnormalities in multiple myeloma: a multi-center study. Blood Cancer J 5:e271CrossRefPubMedPubMedCentral Greenberg AJ, Philip S, Paner A et al (2015) Racial differences in primary cytogenetic abnormalities in multiple myeloma: a multi-center study. Blood Cancer J 5:e271CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Weinhold N, Heuck C, Rosenthal A et al (2016) The clinical value of molecular subtyping multiple myeloma using gene expression profiling. Leukemia 30(2):423–430CrossRefPubMed Weinhold N, Heuck C, Rosenthal A et al (2016) The clinical value of molecular subtyping multiple myeloma using gene expression profiling. Leukemia 30(2):423–430CrossRefPubMed
8.
Zurück zum Zitat Behere PR, Bhattacharyya J, Bithiah GJ (2017) Clinical value of classification of multiple myeloma samples based on their gene expression profiles. Abstract P-PCD04. Indian J Hematol Blood Transfus 33(Abstract Issue: 58th Annual Conference of Indian Society of Hematology and Blood Transfusion):S99 Behere PR, Bhattacharyya J, Bithiah GJ (2017) Clinical value of classification of multiple myeloma samples based on their gene expression profiles. Abstract P-PCD04. Indian J Hematol Blood Transfus 33(Abstract Issue: 58th Annual Conference of Indian Society of Hematology and Blood Transfusion):S99
9.
Zurück zum Zitat Quinn J, Percy L, Glassford J et al (2010) CD20-positive multiple myeloma—differential expression of cyclins D1 and D2 suggests a heterogeneous disease. Br J Haematol 149(1):156–159CrossRefPubMed Quinn J, Percy L, Glassford J et al (2010) CD20-positive multiple myeloma—differential expression of cyclins D1 and D2 suggests a heterogeneous disease. Br J Haematol 149(1):156–159CrossRefPubMed
10.
Zurück zum Zitat Kapoor P, Greipp PT, Morice WG et al (2008) Anti-CD20 monoclonal antibody therapy in multiple myeloma. Br J Haematol 141(2):135–148CrossRefPubMed Kapoor P, Greipp PT, Morice WG et al (2008) Anti-CD20 monoclonal antibody therapy in multiple myeloma. Br J Haematol 141(2):135–148CrossRefPubMed
11.
Zurück zum Zitat Moreau P, Voillat L, Benboukher L et al (2007) Rituximab in CD20 positive multiple myeloma. Leukemia 21(4):835–836CrossRefPubMed Moreau P, Voillat L, Benboukher L et al (2007) Rituximab in CD20 positive multiple myeloma. Leukemia 21(4):835–836CrossRefPubMed
12.
Zurück zum Zitat Padhi S, Varghese RGB, Ramdas A (2013) Cyclin D1 expression in multiple myeloma by immunohistochemistry: case series of 14 patients and literature review. Indian J Med Paediatr Oncol 34(4):283–291CrossRefPubMedPubMedCentral Padhi S, Varghese RGB, Ramdas A (2013) Cyclin D1 expression in multiple myeloma by immunohistochemistry: case series of 14 patients and literature review. Indian J Med Paediatr Oncol 34(4):283–291CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Athanasiou E, Kaloutsi V, Kotoula V et al (2001) Cyclin D1 overexpression in multiple myeloma a morphologic, immunohistochemical, and in situ hybridization study of 71 paraffin-embedded bone marrow biopsy specimens. Am J Clin Pathol 116(4):535–542CrossRefPubMed Athanasiou E, Kaloutsi V, Kotoula V et al (2001) Cyclin D1 overexpression in multiple myeloma a morphologic, immunohistochemical, and in situ hybridization study of 71 paraffin-embedded bone marrow biopsy specimens. Am J Clin Pathol 116(4):535–542CrossRefPubMed
14.
Zurück zum Zitat Yavasoglu I, Sargin G, Kadikoylu G et al (2015) Immunohistochemical evaluation of CD20 expression in patients with multiple myeloma. Revista Brasileira de Hematologia e Hemoterapia 37(1):34–37CrossRefPubMed Yavasoglu I, Sargin G, Kadikoylu G et al (2015) Immunohistochemical evaluation of CD20 expression in patients with multiple myeloma. Revista Brasileira de Hematologia e Hemoterapia 37(1):34–37CrossRefPubMed
15.
Zurück zum Zitat Mallik N, Nampoothiri R, Sreedharanunni S et al (2017) The prognostic impact of CD20 and cyclin D1 expression in multiple myeloma—a pilot study. Abstract P-PCD13. Indian J Hematol Blood Transfus 33(Abstract Issue: 58th Annual Conference of Indian Society of Hematology and Blood Transfusion):S126 Mallik N, Nampoothiri R, Sreedharanunni S et al (2017) The prognostic impact of CD20 and cyclin D1 expression in multiple myeloma—a pilot study. Abstract P-PCD13. Indian J Hematol Blood Transfus 33(Abstract Issue: 58th Annual Conference of Indian Society of Hematology and Blood Transfusion):S126
16.
Zurück zum Zitat Cook JR, Hsi ED, Worley S, Tubbs RR, Hussein M (2006) Immunohistochemical analysis identifies two cyclin D1 + subsets of plasma cell myeloma, each associated with favorable survival. Am J Clin Pathol 125(4):615–624CrossRefPubMed Cook JR, Hsi ED, Worley S, Tubbs RR, Hussein M (2006) Immunohistochemical analysis identifies two cyclin D1 + subsets of plasma cell myeloma, each associated with favorable survival. Am J Clin Pathol 125(4):615–624CrossRefPubMed
18.
Zurück zum Zitat J-j Zhang, W-j Sun, Z-x Huang et al (2014) Light chain multiple myeloma, clinic features, responses to therapy and survival in a long-term study. World J Surg Oncol 12(1):234CrossRef J-j Zhang, W-j Sun, Z-x Huang et al (2014) Light chain multiple myeloma, clinic features, responses to therapy and survival in a long-term study. World J Surg Oncol 12(1):234CrossRef
19.
Zurück zum Zitat Singh N, Agrawal N, Mehta A et al (2017) Light chain myeloma: a single centre experience. Abstract O06. Indian J of Hematol Blood Transfus 33(Abstract Issue: 58th Annual Conference of Indian Society of Hematology and Blood Transfusion):S4 Singh N, Agrawal N, Mehta A et al (2017) Light chain myeloma: a single centre experience. Abstract O06. Indian J of Hematol Blood Transfus 33(Abstract Issue: 58th Annual Conference of Indian Society of Hematology and Blood Transfusion):S4
20.
Zurück zum Zitat Ahmed R, Mehta P, Yadav N et al (2017) Initial experience with daratumumab from a tertiary cancer care centre. Abstract P-PCD06. Indian J Hematol Blood Transfus 33(Abstract Issue: 58th Annual Conference of Indian Society of Hematology and Blood Transfusion):S99 Ahmed R, Mehta P, Yadav N et al (2017) Initial experience with daratumumab from a tertiary cancer care centre. Abstract P-PCD06. Indian J Hematol Blood Transfus 33(Abstract Issue: 58th Annual Conference of Indian Society of Hematology and Blood Transfusion):S99
Metadaten
Titel
Plasma Cell Dyscrasias in India-2017 Updates
verfasst von
Arihant Jain
Pankaj Malhotra
Publikationsdatum
13.12.2017
Verlag
Springer India
Erschienen in
Indian Journal of Hematology and Blood Transfusion / Ausgabe 1/2018
Print ISSN: 0971-4502
Elektronische ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-017-0910-0

Weitere Artikel der Ausgabe 1/2018

Indian Journal of Hematology and Blood Transfusion 1/2018 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.